RAPIDLY PROGRESSIVE INTERSTITIAL LUNG DISEASE IN ASSOCIATION WITH MDA5 ANTIBODY DERMATOMYOSITIS

被引：0
|
作者：
Kazmierski, Dan
Sharma, Nishant
Wang, Yichen
Noumi, Bassel
Ochieng, Pius
Ejaz, Komal
机构：
来源：
CHEST | 2020年 / 158卷 / 04期
关键词：
D O I：
10.1016/j.chest.2020.08.1042
中图分类号：
R4 [临床医学];
学科分类号：
1002 ; 100602 ;
摘要：
引用
收藏
页码：1140A / 1141A
页数：2
相关论文
共 50 条
  • [41] Rapidly progressive interstitial lung disease associated with dermatomyositis-Longitudinal course of anti-MDA5 antibody titer in two cases
    Awaji, Kentaro
    Asano, Yoshihide
    Fukui, Yuki
    Oka, Tomonori
    Toyama, Tetsuo
    Sato, Shinichi
    JOURNAL OF CUTANEOUS IMMUNOLOGY AND ALLERGY, 2021, 4 (04) : 78 - 81
  • [42] Rapidly progressive interstitial lung disease risk prediction in anti-MDA5 positive dermatomyositis: the CROSS model
    Wang, Lei
    Lv, Chengyin
    You, Hanxiao
    Xu, Lingxiao
    Yuan, Fenghong
    Li, Ju
    Wu, Min
    Zhou, Shiliang
    Da, Zhanyun
    Qian, Jie
    Wei, Hua
    Yan, Wei
    Zhou, Lei
    Wang, Yan
    Yin, Songlou
    Zhou, Dongmei
    Wu, Jian
    Lu, Yan
    Su, Dinglei
    Liu, Zhichun
    Liu, Lin
    Ma, Longxin
    Xu, Xiaoyan
    Zang, Yinshan
    Liu, Huijie
    Ren, Tianli
    Liu, Jin
    Wang, Fang
    Zhang, Miaojia
    Tan, Wenfeng
    FRONTIERS IN IMMUNOLOGY, 2024, 15
  • [43] FDG PET/CT Findings of Rapidly Progressive Interstitial Lung Disease in a Patient With Anti-MDA5 Dermatomyositis
    Zhang, Jun
    Dong, Aisheng
    CLINICAL NUCLEAR MEDICINE, 2025, 50 (01) : 80 - 82
  • [44] Successful Polymyxin B Hemoperfusion Treatment Associated With Serial Reduction of Serum Anti-CADM-140/MDA5 Antibody Levels in Rapidly Progressive Interstitial Lung Disease With Amyopathic Dermatomyositis
    Teruya, Aoi
    Kawamura, Kodai
    Ichikado, Kazuya
    Sato, Shinji
    Yasuda, Yuko
    Yoshioka, Masakazu
    CHEST, 2013, 144 (06) : 1934 - 1936
  • [45] COVID-19 Leading to Accelerated Rapidly Progressive Interstitial Lung Disease in Anti-MDA5 Dermatomyositis
    Dandu, S.
    Farhat, F.
    Akhlaq, H.
    Udongwo, N.
    Nannepaga, S.
    Nadhim, A.
    Abu Homoud, A.
    AMERICAN JOURNAL OF RESPIRATORY AND CRITICAL CARE MEDICINE, 2023, 207
  • [46] Risk Prediction for Rapidly Progressive Interstitial Lung Disease in Anti-MDA5-Positive Dermatomyositis: The CRAFT Model
    Guo, Jinqiang
    Mei, Chunli
    Yu, Qi
    Huang, Anbin
    MEDICAL SCIENCE MONITOR, 2023, 29
  • [47] FULMINANT ORGANIZING PNEUMONIA: A CASE OF ANTI-MDA5 AMYOPATHIC DERMATOMYOSITIS WITH RAPIDLY PROGRESSIVE INTERSTITIAL LUNG DISEASE
    Pham, Andrew
    Chesta, F. N. U.
    Castaneda, Christian L.
    CHEST, 2023, 164 (04) : 5732A - 5732A
  • [48] Successful Rescue Therapy With Daratumumab in Rapidly Progressive Interstitial Lung Disease Caused by MDA5-Positive Dermatomyositis
    Holzer, Marie-Therese
    Nies, Jasper F.
    Oqueka, Tim
    Huber, Tobias B.
    Koetter, Ina
    Krusche, Martin
    CHEST, 2023, 163 (01) : E1 - E5
  • [49] RAPIDLY PROGRESSIVE INTERSTITIAL LUNG DISEASE ASSOCIATED WITH MDA-5 ANTIBODIES
    Taylor, Mark
    Berglund, Lucinda
    INTERNAL MEDICINE JOURNAL, 2018, 48 : 33 - 33
  • [50] Mortality risk in patients with anti-MDA5 dermatomyositis is related to rapidly progressive interstitial lung disease and anti-Ro52 antibody
    Wang, Huyan
    Chen, Xin
    Du, Yan
    Wang, Lihua
    Wang, Qiyuan
    Wu, Huaxiang
    Liu, Lei
    Xue, Jing
    ARTHRITIS RESEARCH & THERAPY, 2023, 25 (01)
12345